Millennials: Aurora Cannabis (TSX:ACB) Is a Falling Knife I’d Catch at $4.50

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is absurdly undervalued and could be ripe for a massive upside correction in 2020.

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Millennials still believe in Aurora Cannabis (TSX:ACB)(NYSE:ACB) after the stock’s massive 66% peak-to-trough plunge. But could they get hurt by catching the falling knife with no signs of slowed negative momentum and a potential price war on the horizon?

Moving on from a forgettable first year of legalization

The lights went out on the cannabis sector following nationwide legalization, a time when I warned investors to take their profits off the table over concerns that the black market would continue to thrive in a post-legalization era.

“At this point, it looks like the black market may become a major issue, since the cost per gram of [legal] marijuana is expected to become high, especially if regulators slap a more aggressive tax than expected.” I said in a prior piece.

I called the sky-high demand for legal cannabis, a catalyst that many investors going into legalization were betting on, a “hallucination,” also noting that the black market had more than enough capacity to “fulfill the needs of pot users” and that licensed producers (LPs) would need to “take a hit on the chin to keep [legal marijuana] prices attractive” to deal with the pesky black market.

After going through a federal election that didn’t draw nearly enough attention to the state of legal weed in year one and how to better combat the black market, it seems as though LPs are going to have to take things into their own hands to narrow the legal-to-illegal cannabis price spread, which continues to widen.

Aurora could come out a winner in a potential price war

Aurora Cannabis has solid margins relative to its peers in the space, and while it looks to be a top contender on the road to profitability, not even Aurora will be able to dodge the bullets that could come with a price war that would take a big slice out of margins.

Lower margins over the intermediate term mean profitability will be farther away, which is a massive turn-off for investors who are looking for a sustainability move into the green.

Fighting the black market should really be seen as a double-edged sword, though, not just a mere killer of margins and profitability hopes.

With HEXO poised to produce its own line of budget bud, Aurora and other LPs are likely to follow suit and drive down the price of legal weed.

Although margins would initially flop in such a scenario, the massive amount of sales lost to the black market (40% of cannabis consumers get their weed from the black market) will go right into the top-line of the LPs, resulting in massive top-line growth numbers.

Lower margins, higher sales. That’s not necessarily a bad thing in the grander scheme of things when you consider margins are steadily improving for innovative cultivators like Aurora. For poorly-capitalized firms with lousy margins and low bud yields, though, lower margins could be seen as a nail in the coffin.

Furthermore, at 19.3 times sales, Aurora isn’t exactly in “bubble” territory anymore, as many other hyper-growth stocks, including Beyond Meat, are more expensive based on traditional valuation metrics, with less impressive growth potential.

Foolish takeaway

Sure, the incoming “cannabis 2.0” catalyst is encouraging for young investors who can afford to take on more risk, but as we enter what could be a violent cannabis price war to combat the black market, profitability numbers could be a lot farther away than most young investors are thinking. As such, those hoping for quick profits will be left disappointed.

However, those with a long-term horizon should look to Aurora as a top pick on the way down and view sales growth and margin robustness as the metrics to watch for as profits slip away for the time being.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »